Last Modified: June 30, 2002
Conference Dates: October 3, 2002
Conference Location: Marquis Ballroom, Marriott Marquis, 1535 Broadway, NY, NY 10036
Sponsoring Group: The Multiple Myeloma Research Foundation
Conference Web Page URL: www.multiplemyeloma.org
Conference Objectives: To provide patients, family and friends with a comprehensive overview of the latest biological and clinical research information on myeloma.
Who Should Attend: patient, patient family and friends
Registration Information: Please contact Sarah Davis at the Multiple Myeloma Research Foundation at 203-972-1250 or email email@example.com.
Conference Fees: Free
Continuing Education: No
Dec 21, 2014 - In patients with relapsed or resistant multiple myeloma who have received up to three prior therapies excluding the first-generation proteasome inhibitor bortezomib, treatment with the second-generation proteasome inhibitor carfilzomib is associated a high response rate and a low incidence of side effects, according to research presented at the annual meeting of the American Society of Hematology, held from Dec. 5 to 8 in New Orleans.
Dec 21, 2014